The Food and Drug Administration has officially announced the end of the shortage of Novo Nordisk’s popular drug semaglutide, a development that has significant...
The U.S. Biomedicine Dominance in Peril: Threat of Brain Drain LoomsA sense of unease and uncertainty grips the scientific community as they grapple with...